Clinical Scorecard: Evaluating Blood Transfusion Criteria in Extracorporeal Membrane Oxygenation (ECMO)

At a Glance

Key Highlights

• Haemoglobin concentration is a modifiable factor influencing oxygen delivery during ECMO, constrained by circuit flow and native cardiac function.
• Evidence for optimal transfusion thresholds in ECMO is limited and conflicting, with liberal (9–12 g/dL) versus restrictive (7–9 g/dL) strategies debated.
• Transfusion benefits appear limited to patients with haemoglobin below critical thresholds (~7 g/dL), reflecting oxygen supply–demand mismatch states.

Guideline-Based Recommendations

Diagnosis

• Assess haemoglobin levels in conjunction with clinical indicators of oxygen delivery and consumption rather than relying solely on laboratory thresholds.

Management

• Consider restrictive transfusion strategies (Hb 7–9 g/dL) in ECMO patients unless clinical signs indicate oxygen supply dependency.
• Adjust ECMO circuit flow and haemoglobin concentration dynamically, especially during weaning phases.
• Recognize that VA-ECMO patients have complex competing circulations affecting oxygen delivery, complicating transfusion decisions.

Monitoring & Follow-up

• Monitor haemoglobin concentration, microcirculatory perfusion, and signs of oxygen supply–demand mismatch continuously.
• Be vigilant for bleeding complications and coagulopathy influencing transfusion needs and outcomes.

Risks

• Transfusion-related increases in blood viscosity may not linearly improve oxygen delivery and could impair microcirculatory flow.
• Liberal transfusion strategies may not confer survival benefits beyond early ECMO support and may increase complications.

Patient & Prescribing Data

Patients on VA-ECMO and VV-ECMO support, including those with COVID-19-related ARDS

Liberal transfusion (Hb ≥ 9 g/dL) showed early survival benefit in VA-ECMO but no long-term advantage; VV-ECMO patients benefit from transfusion only when Hb < 7 g/dL.

Clinical Best Practices

• Individualize transfusion decisions based on physiological need rather than fixed haemoglobin thresholds.
• Incorporate dynamic assessment of oxygen delivery and consumption ratios to guide transfusion.
• Recognize the limitations of haemoglobin concentration as a sole transfusion trigger in ECMO patients.
• Consider the unique physiology of VA-ECMO with competing circulations when evaluating transfusion thresholds.
• Remain cautious of transfusion-related risks including increased blood viscosity and potential complications.

References

• Extracorporeal Life Support Organization (ELSO) Guidelines
• OBLEX Study on VA-ECMO Transfusion Strategies
• PROTECMO Study on VV-ECMO Transfusion